Meridian Bioscience, Inc. Expects to Report Fiscal 2018 Revenue and Earnings Guidance on Thursday, October 19, 2017
CINCINNATI, Oct. 16, 2017 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its fiscal 2018 Revenue and Earnings Guidance before the NASDAQ market opens on Thursday, October 19. The release will be available shortly thereafter on Meridian’s website at www.meridianbioscience.com. About Meridian Bioscience, Inc. Meridian is […]